Publication:
Efficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality

Simple item page
dc.contributor.authorKASAPOĞLU, UMUT SABRİ
dc.contributor.authorsACUN DELEN L., KASAPOĞLU U. S. , GÖK A., ÇAĞAŞAR Ö., TETİK B., ÖKSÜZ E.
dc.date.accessioned2022-11-01T07:36:35Z
dc.date.accessioned2026-01-10T19:17:27Z
dc.date.available2022-11-01T07:36:35Z
dc.date.issued2022-10-01
dc.identifier.citationACUN DELEN L., KASAPOĞLU U. S. , GÖK A., ÇAĞAŞAR Ö., TETİK B., ÖKSÜZ E., "Efficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality", MARMARA MEDICAL JOURNAL, cilt.35, sa.3, ss.308-315, 2022
dc.identifier.doi10.5472/marumj.1191126
dc.identifier.endpage315
dc.identifier.issn1019-1941
dc.identifier.issue3
dc.identifier.startpage308
dc.identifier.urihttps://dergipark.org.tr/en/pub/marumj/issue/73229/1191126
dc.identifier.urihttps://hdl.handle.net/11424/282748
dc.identifier.volume35
dc.language.isoeng
dc.relation.ispartofMARMARA MEDICAL JOURNAL
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleEfficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
280.31 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları